TXMD Price / Book | TherapeuticsMD, Inc.

TherapeuticsMD, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

TherapeuticsMD, Inc. price/book ratio for the quarter ending 2026-06-30 was 0.94, a 85.25% increase year-over-year.
TherapeuticsMD, Inc. price/book ratio for the quarter ending 2026-03-31 was 0.88, a 118.53% increase year-over-year.
TherapeuticsMD, Inc. price/book ratio for the quarter ending 2025-12-31 was 0.7, a 93.13% increase year-over-year.
TherapeuticsMD, Inc. price/book ratio for the quarter ending 2025-09-30 was 0.45, a 35.84% decline year-over-year.
TherapeuticsMD, Inc. price/book ratio for fiscal 2026 was 0.94.
TherapeuticsMD, Inc. price/book ratio for fiscal 2025 was 0.7, a 93.13% increase from fiscal 2024.
TherapeuticsMD, Inc. price/book ratio for fiscal 2024 was 0.36, a 59.10% decline from fiscal 2023.
TherapeuticsMD, Inc. price/book ratio for fiscal 2023 was 0.89, a 41.36% decline from fiscal 2022.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	0.94	$25.58M	$27.13M
2026-03-31	0.88	$23.73M	$26.97M
2025-12-31	0.7	$18.81M	$26.88M
2025-09-30	0.45	$12.44M	$27.44M
2025-06-30	0.51	$13.89M	$27.29M
2025-03-31	0.4	$10.76M	$26.74M
2024-12-31	0.36	$9.92M	$27.37M
2024-09-30	0.71	$19.14M	$27.09M
2024-06-30	0.67	$18.57M	$27.67M
2024-03-31	0.92	$26.41M	$28.66M
2023-12-31	0.89	$25.95M	$29.29M
2023-09-30	1.14	$31.94M	$28.05M
2023-06-30	1.4	$43.57M	$31.2M
2023-03-31	1.12	$35.81M	$32.02M
2022-12-31	1.51	$53.09M	$35.14M
2022-09-30	-1.3	$62.86M	-$48.27M
2022-06-30	-3.38	$88.16M	-$26.07M
2022-03-31	-1.17	$164.71M	-$140.58M
2021-12-31	-1.65	$154.76M	-$93.62M
2021-09-30	-274.07	$15.72B	-$57.36M
2021-06-30	-478.98	$23.51B	-$49.07M
2021-03-31	-2,779.46	$26.34B	-$9.48M
2020-12-31	-146.26	$18.14B	-$124M
2020-09-30	-185.74	$21.55B	-$116.03M
2020-06-30	-180.88	$17.02B	-$94.09M
2020-03-31	-318.49	$14.4B	-$45.21M
2019-12-31	3,566.18	$32.81B	$9.2M
2019-09-30	-2,062.84	$43.79B	-$21.23M
2019-06-30	3,874.35	$31.36B	$8.09M
2019-03-31	967.78	$58.74B	$60.69M
2018-12-31	469.71	$45.81B	$97.52M
2018-09-30	577.88	$77.56B	$134.22M
2018-06-30	872.42	$67.65B	$77.55M
2018-03-31	491.49	$52.74B	$107.3M
2017-12-31	503.14	$65.36B	$129.91M
2017-09-30	382.95	$57.25B	$149.48M
2017-06-30	574.43	$53.76B	$93.59M
2017-03-31	647.97	$71.49B	$110.33M
2016-12-31	445.09	$56.74B	$127.49M
2016-09-30	457.35	$66.94B	$146.35M
2016-06-30	499.31	$83.51B	$167.25M
2016-03-31	342.3	$62.77B	$183.37M
2015-12-31	1,462.91	$92.26B	$63.06M
2015-09-30	671.66	$52.09B	$77.56M
2015-06-30	1,079.33	$68B	$63.01M
2015-03-31	595.41	$52.23B	$87.72M
2014-12-31	717.76	$34.73B	$48.39M
2014-09-30	569.16	$36.2B	$63.6M
2014-06-30	860.39	$32.25B	$37.48M
2014-03-31	979	$45.77B	$46.75M
2013-12-31	690.45	$37.77B	$54.7M
2013-09-30	342.05	$21.24B	$62.09M
2013-06-30	516.78	$19.88B	$38.47M
2013-03-31	291.11	$11.63B	$39.94M
2012-12-31	-10,792.25	$15.47B	-$1.43M
2012-09-30	-3,971.76	$17.21B	-$4.33M
2012-06-30	-19,030.29	$13.41B	-$704,405.00
2012-03-31	-3,036.63	$10.18B	-$3.35M
2011-12-31	-3,635.47	$6.22B	-$1.71M
2011-09-30	-1,928.66	$828.76M	-$429,709.00
2011-06-30	-2,359.94	$828.76M	-$351,178.00
2010-12-31	-9,170.93	$8.32B	-$907,552.00

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	0.94	$25.58M	$27.13M
2025-12-31	0.7	$18.81M	$26.88M
2024-12-31	0.36	$9.92M	$27.37M
2023-12-31	0.89	$25.95M	$29.29M
2022-12-31	1.51	$53.09M	$35.14M
2021-12-31	-1.65	$154.76M	-$93.62M
2020-12-31	-146.26	$18.14B	-$124M
2019-12-31	3,566.18	$32.81B	$9.2M
2018-12-31	469.71	$45.81B	$97.52M
2017-12-31	503.14	$65.36B	$129.91M
2016-12-31	445.09	$56.74B	$127.49M
2015-12-31	1,462.91	$92.26B	$63.06M
2014-12-31	717.76	$34.73B	$48.39M
2013-12-31	690.45	$37.77B	$54.7M
2012-12-31	-10,792.25	$15.47B	-$1.43M
2011-12-31	-3,635.47	$6.22B	-$1.71M
2010-12-31	-9,170.93	$8.32B	-$907,552.00

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62
ARTELO BIOSCIENCES, INC. (ARTL)	United States	$0.023B
Cocrystal Pharma, Inc. (COCP)	United States	$0.022B
ATOSSA THERAPEUTICS, INC. (ATOS)	United States	$0.021B	-0.52
KYNTRA BIO, INC. (KYNB)	United States	$0.028B	0.17
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
Hepion Pharmaceuticals, Inc. (HEPA)	United States	$0.029B	-0.62
Neuphoria Therapeutics Inc. (NEUP)	United States	$0.020B	-1.77
Marker Therapeutics, Inc. (MRKR)	United States	$0.020B	-2.86